{
    "organizations": [],
    "uuid": "036d9b791e6fc6662996704ecc489742cd4e9207",
    "author": "",
    "url": "https://www.reuters.com/article/brief-gw-pharma-says-mid-stage-study-of/brief-gw-pharma-says-mid-stage-study-of-seizures-drug-failed-main-goal-idUSFWN1QB0YM",
    "ord_in_thread": 0,
    "title": "BRIEF-GW Pharma Says Mid Stage Study Of Seizures Drug Failed Main Goal",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 21, 2018 / 9:12 PM / Updated 13 minutes ago BRIEF-GW Pharma Says Mid Stage Study Of Seizures Drug Failed Main Goal Reuters Staff Feb 21 (Reuters) - GW Pharmaceuticals Plc: * GW PHARMACEUTICALS ANNOUNCES PRELIMINARY RESULTS OF PHASE 2A STUDY FOR ITS PIPELINE COMPOUND GWP42006 * GW PHARMA - PHASE 2A PROOF OF CONCEPT STUDY OF A PIPELINE COMPOUND GWP42006 IN ADULT PATIENTS WITH FOCAL SEIZURES DID NOT MEET ITS PRIMARY ENDPOINT Source text for Eikon: Further company coverage:",
    "published": "2018-02-21T23:11:00.000+02:00",
    "crawled": "2018-02-21T23:34:00.049+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharma",
        "say",
        "mid",
        "stage",
        "study",
        "seizure",
        "drug",
        "failed",
        "main",
        "goal",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "gw",
        "pharmaceutical",
        "plc",
        "gw",
        "pharmaceutical",
        "announces",
        "preliminary",
        "result",
        "phase",
        "2a",
        "study",
        "pipeline",
        "compound",
        "gwp42006",
        "gw",
        "pharma",
        "phase",
        "2a",
        "proof",
        "concept",
        "study",
        "pipeline",
        "compound",
        "gwp42006",
        "adult",
        "patient",
        "focal",
        "seizure",
        "meet",
        "primary",
        "endpoint",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}